127.75
전일 마감가:
$129.34
열려 있는:
$130.02
하루 거래량:
1.72M
Relative Volume:
1.16
시가총액:
$18.73B
수익:
$9.82B
순이익/손실:
$1.48B
주가수익비율:
12.61
EPS:
10.13
순현금흐름:
$2.30B
1주 성능:
-0.20%
1개월 성능:
-1.83%
6개월 성능:
-9.62%
1년 성능:
-36.05%
Biogen Inc Stock (BIIB) Company Profile
명칭
Biogen Inc
전화
(781) 464-2000
주소
225 BINNEY STREET, CAMBRIDGE, MA
BIIB을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BIIB
Biogen Inc
|
127.75 | 18.96B | 9.82B | 1.48B | 2.30B | 10.13 |
![]()
LLY
Lilly Eli Co
|
640.86 | 670.04B | 49.00B | 11.11B | -1.27B | 12.29 |
![]()
JNJ
Johnson Johnson
|
171.53 | 410.84B | 90.63B | 22.66B | 16.40B | 9.35 |
![]()
ABBV
Abbvie Inc
|
198.86 | 346.78B | 58.33B | 3.76B | 18.24B | 2.10 |
![]()
NVS
Novartis Ag Adr
|
115.92 | 219.72B | 55.19B | 13.65B | 16.81B | 6.86 |
![]()
MRK
Merck Co Inc
|
80.37 | 198.42B | 63.62B | 16.41B | 14.72B | 6.49 |
Biogen Inc Stock (BIIB) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-21 | 재개 | Truist | Hold |
2025-04-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
2025-04-04 | 다운그레이드 | Argus | Buy → Hold |
2025-02-11 | 개시 | Bernstein | Mkt Perform |
2025-01-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
2024-12-16 | 다운그레이드 | Stifel | Buy → Hold |
2024-12-10 | 재개 | BofA Securities | Neutral |
2024-12-09 | 다운그레이드 | Jefferies | Buy → Hold |
2024-11-18 | 다운그레이드 | Needham | Buy → Hold |
2024-11-15 | 개시 | Wolfe Research | Peer Perform |
2024-11-14 | 개시 | Citigroup | Neutral |
2024-10-31 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2024-10-10 | 재개 | Raymond James | Mkt Perform |
2024-02-14 | 재확인 | Needham | Buy |
2024-02-14 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2024-01-24 | 다운그레이드 | UBS | Buy → Neutral |
2023-12-20 | 재개 | Cantor Fitzgerald | Overweight |
2023-12-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2023-09-06 | 개시 | HSBC Securities | Buy |
2023-07-27 | 개시 | Scotiabank | Sector Outperform |
2023-07-24 | 재확인 | UBS | Buy |
2023-05-01 | 업그레이드 | Guggenheim | Neutral → Buy |
2023-04-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2022-10-26 | 업그레이드 | Goldman | Neutral → Buy |
2022-10-13 | 업그레이드 | Stifel | Hold → Buy |
2022-10-07 | 업그레이드 | Argus | Hold → Buy |
2022-09-28 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
2022-09-28 | 업그레이드 | Mizuho | Neutral → Buy |
2022-09-28 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2022-04-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2022-03-08 | 다운그레이드 | Stifel | Buy → Hold |
2022-03-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2022-02-04 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
2022-02-04 | 재확인 | Barclays | Equal Weight |
2022-02-04 | 재확인 | BofA Securities | Neutral |
2022-02-04 | 재확인 | Cowen | Outperform |
2022-02-04 | 재확인 | Morgan Stanley | Overweight |
2022-02-04 | 재확인 | Needham | Buy |
2022-02-04 | 재확인 | Oppenheimer | Outperform |
2022-02-04 | 재확인 | RBC Capital Mkts | Sector Perform |
2022-02-04 | 재확인 | Robert W. Baird | Neutral |
2022-02-04 | 재확인 | Wedbush | Neutral |
2022-02-04 | 재확인 | Wells Fargo | Equal Weight |
2022-02-04 | 재확인 | Wolfe Research | Peer Perform |
2022-01-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
2022-01-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2021-12-10 | 재개 | Raymond James | Mkt Perform |
2021-12-09 | 재개 | Wells Fargo | Equal Weight |
2021-12-06 | 개시 | Goldman | Neutral |
2021-11-19 | 개시 | BMO Capital Markets | Outperform |
2021-09-23 | 개시 | Needham | Buy |
2021-06-18 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2021-06-14 | 재확인 | Truist | Buy |
2021-06-11 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
2021-06-10 | 업그레이드 | UBS | Neutral → Buy |
2021-06-08 | 업그레이드 | Atlantic Equities | Underweight → Neutral |
2021-06-08 | 재확인 | Barclays | Equal Weight |
2021-06-08 | 업그레이드 | Citigroup | Sell → Neutral |
2021-06-08 | 재확인 | H.C. Wainwright | Buy |
2021-06-08 | 재확인 | Jefferies | Buy |
2021-06-08 | 재확인 | Morgan Stanley | Overweight |
2021-06-08 | 재확인 | RBC Capital Mkts | Sector Perform |
2021-06-08 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
2021-06-08 | 재확인 | Stifel | Buy |
2021-06-08 | 업그레이드 | William Blair | Mkt Perform → Outperform |
2021-06-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
2021-06-07 | 업그레이드 | Cowen | Market Perform → Outperform |
2021-06-07 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
2021-02-05 | 다운그레이드 | DZ Bank | Buy → Hold |
2021-01-29 | 업그레이드 | Stifel | Hold → Buy |
2020-11-10 | 업그레이드 | DZ Bank | Hold → Buy |
2020-11-09 | 다운그레이드 | Atlantic Equities | Neutral → Underweight |
2020-11-09 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2020-11-09 | 다운그레이드 | Cowen | Outperform → Market Perform |
2020-11-09 | 재확인 | H.C. Wainwright | Buy |
2020-11-04 | 업그레이드 | BofA Securities | Underperform → Neutral |
2020-11-04 | 업그레이드 | Jefferies | Hold → Buy |
2020-11-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2020-10-28 | 개시 | UBS | Neutral |
2020-07-27 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
2020-06-22 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2020-06-22 | 재확인 | RBC Capital Mkts | Sector Perform |
2020-06-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
2020-04-23 | 다운그레이드 | Citigroup | Neutral → Sell |
2020-04-23 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
2020-03-31 | 개시 | Wolfe Research | Peer Perform |
2020-02-27 | 개시 | Barclays | Overweight |
2020-01-27 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2019-12-13 | 업그레이드 | Credit Suisse | Underperform → Neutral |
2019-12-02 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
모두보기
Biogen Inc 주식(BIIB)의 최신 뉴스
iA Global Asset Management Inc. Acquires 2,636 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Arkadios Wealth Advisors Purchases Shares of 3,354 Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Position Cut by J. Safra Sarasin Holding AG - MarketBeat
Eli Lilly And Biogen (And Eisai): Muddying The Waters In Alzheimer's Disease - Seeking Alpha
Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment? - TipRanks
We Think Biogen's (NASDAQ:BIIB) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Primecap Management Co. CA Lowers Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Bank of Nova Scotia Sells 4,241 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Natixis Advisors LLC Acquires 9,946 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
What is William Blair's Forecast for Biogen Q2 Earnings? - MarketBeat
Global Renal Transplant Therapeutics Market is Expected to Cross ~USD 18 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates - MSN
Japan OKs Price Cut for Alzheimer's Drug Lecanemab - JIJI PRESS
US Bancorp DE Has $3.55 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Cantor Fitzgerald Brokers Lift Earnings Estimates for Biogen - MarketBeat
Biogen (NASDAQ:BIIB) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Biogen (NASDAQ:BIIB) Price Target Raised to $135.00 at Citigroup - MarketBeat
Biogen (BIIB) Price Target Hiked to $130 at UBS amid Leqembi Development - MSN
Spinal Muscular Atrophy Market Opportunities and Future Scope - openPR.com
Fund Update: STATE OF MICHIGAN RETIREMENT SYSTEM added 251,600 shares of BIOGEN ($BIIB) to their portfolio - Quiver Quantitative
LSV Asset Management Grows Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Y Intercept Hong Kong Ltd Sells 13,310 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Royal Bank Of Canada Issues Positive Forecast for Biogen (NASDAQ:BIIB) Stock Price - MarketBeat
HC Wainwright Issues Positive Forecast for Biogen (NASDAQ:BIIB) Stock Price - MarketBeat
Spinal Muscular Atrophy Pipeline Outlook 2025: Clinical trials, EMA, PDMA, FDA Approvals, Medication, Treatment Market, NDA Approval, Therapies, ROA, MOA and Companies by DelveInsight - Barchart.com
Biogen Inc. (BIIB): A Bull Case Theory - Insider Monkey
Biogen moving ‘rapidly’ in quest to bring salanersen to SMA patients - SMA News Today
BofA Lowers PT on Biogen (BIIB) to $142 From $143, Keeps a Neutral Rating - Insider Monkey
Chronic Lymphocytic Leukemia Therapeutics Market is Fueled - openPR.com
Banco Santander S.A. Purchases 7,182 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen is building a ‘ventures’ team to ‘keep early portfolio externalized’ - Endpoints News
Reversal Confirmed Biogen Inc. Stock Rallies Above MAReal-Time Trade Insights Spark Market Reactions - beatles.ru
Biogen (NASDAQ:BIIB) Updates FY 2025 Earnings Guidance - MarketBeat
Nicolet Advisory Services LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen's Earnings Beat and Leqembi Progress Might Change The Case For Investing In BIIB - simplywall.st
Biogen Stock (BIIB): Strong Q2 Performance Fuels Growth - Value The Markets
RBC Capital Maintains a Buy on Biogen (BIIB) With a $208 PT - MSN
Wedbush Forecasts Biogen's Q3 Earnings (NASDAQ:BIIB) - MarketBeat
Leerink Partnrs Estimates Biogen's Q3 Earnings (NASDAQ:BIIB) - MarketBeat
Tredje AP fonden Purchases New Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Banque Cantonale Vaudoise Invests $1.35 Million in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
XTX Topco Ltd Buys 14,459 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
When is Biogen Inc. stock expected to show significant growthAchieve breakthrough profits with smart strategies - Jammu Links News
What drives Biogen Inc. stock priceAchieve rapid portfolio appreciation - jammulinksnews.com
11 Cheap Pharmaceutical Stocks to Buy Now - Insider Monkey
How does Biogen Inc. compare to its industry peersGet daily expert analysis for smarter investing - Jammu Links News
Biogen (NASDAQ:BIIB) Releases Earnings Results, Beats Expectations By $1.54 EPS - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Stock Holdings Boosted by R Squared Ltd - MarketBeat
Jefferies Financial Group Inc. Has $6.84 Million Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Mackenzie Financial Corp Acquires 12,838 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
What catalysts could drive Biogen Inc. stock higher in 2025Unlock high-yield investment opportunities - jammulinksnews.com
Biogen Inc (BIIB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):